Scott Kogan - Publications

Affiliations: 
Biomedical Sciences University of California, San Francisco, San Francisco, CA 
Area:
Molecular Biology, Cell Biology

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Qi Z, Wen KW, Ki A, Prakash S, Kogan S, Yu J. Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia. Cytogenetic and Genome Research. 1-5. PMID 35675801 DOI: 10.1159/000525010  0.329
2021 Morales CE, Stieglitz E, Kogan SC, Loh ML, Braun BS. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Blood Advances. PMID 34464969 DOI: 10.1182/bloodadvances.2020003754  0.312
2020 Wong JC, Perez-Mancera PA, Huang TQ, Kim J, Grego-Bessa J, Alzamora MDP, Kogan SC, Sharir A, Keefe SH, Morales CE, Schanze D, Castel P, Hirose K, Huang GN, Zenker M, et al. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice. Jci Insight. PMID 32990679 DOI: 10.1172/jci.insight.140495  0.328
2020 Zambetti NA, Firestone AJ, Remsberg JR, Huang BJ, Wong JC, Long AM, Predovic M, Suciu RM, Inguva A, Kogan SC, Haigis KM, Cravatt BF, Shannon K. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. Blood. PMID 32219446 DOI: 10.1182/Blood.2019003530  0.305
2020 Mas Martin G, Man N, Karl D, Martinez C, Duffort S, Itonaga H, Mookhtiar AK, Bilbao D, Kunkalla K, Valencia AM, Collings C, Kadoch C, Vega F, Kogan SC, Nimer S. The Baf Subunit Dpf2 Regulates Resolution of Inflammation By Controlling Macrophage Differentiation Transcription Factor Networks Blood. 136: 13-13. DOI: 10.1182/BLOOD-2020-142030  0.325
2019 Esnault C, Rahmé R, Rice KL, Berthier C, Gaillard C, Quentin S, Maubert AL, Kogan S, de Thé H. FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. Blood. PMID 30674471 DOI: 10.1182/Blood-2018-07-866095  0.363
2018 Gaillard C, Surianarayanan S, Bentley T, Warr MR, Fitch B, Geng H, Passegué E, de Thé H, Kogan SC. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Blood Advances. 2: 2462-2466. PMID 30266821 DOI: 10.1182/bloodadvances.2018018929  0.437
2018 Lehmann-Che J, Bally C, Letouzé E, Berthier C, Yuan H, Jollivet F, Ades L, Cassinat B, Hirsch P, Pigneux A, Mozziconacci MJ, Kogan S, Fenaux P, de Thé H. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Nature Communications. 9: 2047. PMID 29795382 DOI: 10.1038/S41467-018-04384-5  0.443
2018 Nielsen AB, Zhou M, Smith Ad, McCoy L, Hansen H, Bracci P, Morimoto L, Kogan S, Metayer C, Ma X, Wiemels J. Abstract 3241: Children with acute lymphoblastic leukemia have increased arginase 2 at birth, implicating immunosuppression in leukemogenesis Cancer Research. 78: 3241-3241. DOI: 10.1158/1538-7445.Am2018-3241  0.307
2017 Voisset E, Moravcsik E, Stratford EW, Jaye A, Palgrave CJ, Hills RK, Salomoni P, Kogan SC, Solomon E, Grimwade D. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. Blood. PMID 29191918 DOI: 10.1182/Blood-2017-07-794784  0.33
2017 Foley N, Van Ziffle J, Yu J, Qi Z, Grenert JP, Yeh I, Bastian B, Kogan S, Mannis GN. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? Cancer Genetics. 216: 74-78. PMID 29025598 DOI: 10.1016/J.Cancergen.2017.07.002  0.478
2016 Francis SS, Wallace AD, Wendt GA, Li L, Liu F, Riley LW, Kogan S, Walsh KM, de Smith AJ, Dahl GV, Ma X, Delwart E, Metayer C, Wiemels JL. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. PMID 27979823 DOI: 10.1182/Blood-2016-07-723148  0.301
2016 Keeshan K, Vieugue' P, Chaudhury S, Rishi L, Gaillard C, Liang L, Garcia E, Nakamura T, Omidvar N, Kogan SC. Cooperative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveal C/EBPα as a common target of TRIB1 and PML/RARA. Haematologica. PMID 27390356 DOI: 10.3324/haematol.2015.138503  0.482
2016 Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick A, Le Beau MM, Kogan S, et al. Dnmt3a haploinsufficiency transforms Flt3-ITD myeloproliferative disease into a rapid, spontaneous, and fully-penetrant acute myeloid leukemia. Cancer Discovery. PMID 27016502 DOI: 10.1158/2159-8290.Cd-16-0008  0.532
2015 Wong JC, Weinfurtner KM, Alzamora MD, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen SC, Ho TT, Flach J, Reynaud D, Passegué E, Downing JR, et al. Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife. 4. PMID 26193121 DOI: 10.7554/Elife.07839  0.396
2015 Gaillard C, Tokuyasu TA, Rosen G, Sotzen J, Vitaliano-Prunier A, Roy R, Passegué E, de Thé H, Figueroa ME, Kogan SC. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Haematologica. 100: 1064-75. PMID 26088929 DOI: 10.3324/Haematol.2014.123018  0.345
2015 Brondfield S, Umesh S, Corella A, Zuber J, Rappaport AR, Gaillard C, Lowe SW, Goga A, Kogan SC. Direct and indirect targeting of MYC to treat acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 76: 35-46. PMID 25956709 DOI: 10.1007/S00280-015-2766-Z  0.384
2015 Zhao Z, Chen CC, Rillahan CD, Shen R, Kitzing T, McNerney ME, Diaz-Flores E, Zuber J, Shannon K, Le Beau MM, Spector MS, Kogan SC, Lowe SW. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nature Genetics. 47: 539-43. PMID 25822087 DOI: 10.1038/Ng.3251  0.366
2014 Burgess MR, Hwang E, Firestone AJ, Huang T, Xu J, Zuber J, Bohin N, Wen T, Kogan SC, Haigis KM, Sampath D, Lowe S, Shannon K, Li Q. Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood. 124: 3947-55. PMID 25361812 DOI: 10.1182/Blood-2014-05-574582  0.404
2014 Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia Cancer Cell. 25: 652-665. PMID 24794707 DOI: 10.1016/J.Ccr.2014.03.016  0.374
2014 Burgess MR, Hwang E, Firestone AJ, Huang T, Xu J, Zuber J, Bohin N, Wen T, Kogan SC, Haigis KM, Lowe SW, Shannon K, Li Q. Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia Blood. 124: 3753-3753. DOI: 10.1182/Blood.V124.21.3753.3753  0.394
2014 Wong JC, Weinfurtner K, Alzamora P, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen S, Flach J, Reynaud D, Passegue E, Downing JR, Shannon K. Aberrant Hematopoietic Stem Cell Function in Mice Haploinsufficient for a 2 Mb Deletion of Chromosome 5A3 Syntenic to a Region of Human 7q22 Frequently Deleted in Myelodysplastic Syndromes Blood. 124: 3247-3247. DOI: 10.1182/Blood.V124.21.3247.3247  0.407
2013 Li M, Jones L, Gaillard C, Binnewies M, Ochoa R, Garcia E, Lam V, Wei G, Yang W, Lobe C, Hermiston M, Passegué E, Kogan SC. Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations. Leukemia. 27: 1570-3. PMID 23443342 DOI: 10.1038/Leu.2013.15  0.471
2013 Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. The Journal of Clinical Investigation. 123: 335-9. PMID 23221337 DOI: 10.1172/Jci63193  0.435
2013 Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice. Haematologica. 98: 424-7. PMID 23144197 DOI: 10.3324/Haematol.2011.057067  0.453
2013 Moravcsik E, Joannides M, Voisset E, Stratford EW, Zeisig BB, Morris J, Densham R, Palgrave C, Stamp G, Nye E, Hills RK, Salomoni P, So CWE, Kogan SC, Solomon E, et al. Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia Blood. 122: 3721-3721. DOI: 10.1182/Blood.V122.21.3721.3721  0.41
2012 Bagley BN, Keane TM, Maklakova VI, Marshall JG, Lester RA, Cancel MM, Paulsen AR, Bendzick LE, Been RA, Kogan SC, Cormier RT, Kendziorski C, Adams DJ, Collier LS. A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis. Plos Genetics. 8: e1003034. PMID 23133403 DOI: 10.1371/Journal.Pgen.1003034  0.455
2012 Choi G, Huang B, Pinarbasi E, Braunstein SE, Horvai AE, Kogan S, Bhatia S, Faddegon B, Nakamura JL. Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. Cancer Research. 72: 6425-34. PMID 23071067 DOI: 10.1158/0008-5472.Can-12-1728  0.355
2012 Bergerson RJ, Collier LS, Sarver AL, Been RA, Lugthart S, Diers MD, Zuber J, Rappaport AR, Nixon MJ, Silverstein KA, Fan D, Lamblin AF, Wolff L, Kersey JH, Delwel R, ... ... Kogan SC, et al. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Blood. 119: 4512-23. PMID 22427200 DOI: 10.1182/Blood-2010-04-281428  0.472
2012 Gaillard CM, Tokuyasu TA, Passegué E, Kogan SC. PML-RARα Deregulates an Unexpectedly Small Number of Genes in Pre-Leukemic Promyelocytes Blood. 120: 3526-3526. DOI: 10.1182/blood.v120.21.3526.3526  0.404
2011 Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, et al. Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response. Science Translational Medicine. 3: 100ra90. PMID 21918107 DOI: 10.1126/Scitranslmed.3002814  0.341
2011 Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Fellman C, Taylor MJ, Weissenboeck M, Graeber TG, Kogan SC, Vakoc CR, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes & Development. 25: 1628-40. PMID 21828272 DOI: 10.1101/Gad.17269211  0.315
2011 Scaglioni PP, Cai LF, Majid SM, Yung TM, Socci ND, Kogan SC, Kopelovich L, Pandolfi PP. Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. Genes & Cancer. 2: 160-5. PMID 21779489 DOI: 10.1177/1947601911410300  0.339
2011 Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miething C, Scuoppo C, Zuber J, Dickins RA, Kogan SC, Shroyer KR, Sordella R, Hannon GJ, Lowe SW. A rapid and scalable system for studying gene function in mice using conditional RNA interference Cell. 145: 145-158. PMID 21458673 DOI: 10.1016/J.Cell.2011.03.012  0.304
2011 Li Q, Haigis KM, McDaniel A, Harding-Theobald E, Kogan SC, Akagi K, Wong JC, Braun BS, Wolff L, Jacks T, Shannon K. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Blood. 117: 2022-32. PMID 21163920 DOI: 10.1182/Blood-2010-04-280750  0.435
2011 Bagley BN, Maklakova V, Kendziorski C, Adams DJ, Collier LS, Marshall JG, Lester RA, Cancel MM, Bendzick LG, Keane T, Kogan SC, Sullivan R, Cormier R. Abstract A37: A dominantly acting allele of murine Mcm4 causes chromosome instability and promotes leukemiogenesis Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A37  0.431
2010 Jones L, Wei G, Sevcikova S, Phan V, Jain S, Shieh A, Wong JC, Li M, Dubansky J, Maunakea ML, Ochoa R, Zhu G, Tennant TR, Shannon KM, Lowe SW, ... ... Kogan SC, et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. The Journal of Experimental Medicine. 207: 2581-94. PMID 21059853 DOI: 10.1084/Jem.20091071  0.687
2010 Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R. PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia. Cancer Research. 70: 8792-801. PMID 20861188 DOI: 10.1158/0008-5472.Can-08-4481  0.382
2010 Wong JC, Zhang Y, Lieuw KH, Tran MT, Forgo E, Weinfurtner K, Alzamora P, Kogan SC, Akagi K, Wolff L, Le Beau MM, Killeen N, Shannon K. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Blood. 115: 4524-32. PMID 20233966 DOI: 10.1182/Blood-2009-07-232504  0.365
2010 Padua RA, Beurlet S, Krief P, Omidvar N, Pogam CL, Auboeuf D, de la Grange P, Soulie A, Janin A, Noguera M, Merlet P, Sarda-Mantel L, Fenaux P, Konopleva M, Andreeff M, ... ... Kogan SC, et al. ABT-737 Targets Leukemic Stem Cells In Mouse Models of Mutant NRASD12/hBCL-2- Mediated Acute Myeloid Leukemia Progression with Increased Survival Blood. 116: 3308-3308. DOI: 10.1182/Blood.V116.21.3308.3308  0.381
2010 Omidvar N, Pogam CL, Beurlet S, Noguera M, Janin A, Kogan SC, Weissman IL, Pla M, Chomienne C, Padua RA. Mutant BCL2 Co-Operates with CBFβ/PEBP2β-MYH11 to Promote Expansion of Leukemia Initiating Cells with a Predominantly Pro-Apoptotic Mechanism Via Recruitment of Ras-GTP In a Mouse Model of Progressive Acute Myeloid Leukemia. Blood. 116: 1050-1050. DOI: 10.1182/BLOOD.V116.21.1050.1050  0.488
2009 Bergerson RJ, Collier LS, Lugthart S, Allaei R, Nixon MJ, Silverstein KA, Sarver A, Fan DF, Lamblin AJ, Wolff L, Kersey JH, O'Sullivan MG, Delwel R, Kogan SC, Adams DJ, et al. An Insertional Mutagenesis Screen for Genes That Cooperate with Mll-AF9 in Leukemogenesis. Blood. 114: 3962-3962. DOI: 10.1182/Blood.V114.22.3962.3962  0.438
2008 Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegué E, Sage J. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell. 3: 416-28. PMID 18940733 DOI: 10.1016/J.Stem.2008.07.009  0.36
2008 Nagasubramanian R, Hansen RJ, Delaney SM, Cherian MM, Samson LD, Kogan SC, Dolan ME. Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure. Mutagenesis. 23: 341-6. PMID 18477655 DOI: 10.1093/Mutage/Gen018  0.346
2008 Omidvar N, Beurlet S, Le Pogam C, Janin A, Leboeuf C, Soulie A, Setterblad N, Noguera M, Sarda-Mantel L, Merlet P, Pla M, Kogan SC, Weissman IL, Konopleva M, Bormann W, et al. ABT-737 Targets Intrinsic Apoptosis during Cooperation of BCL-2 and Oncogenic NRAS in An in Vivo Progression Model of Myelodysplasia/Acute Myeloid Leukaemia Blood. 112: 848-848. DOI: 10.1182/Blood.V112.11.848.848  0.361
2008 Jones L, Sevcikova S, Phan V, Jain S, Shieh A, Dubansky J, Li M, Maunakea ML, Zhu G, Tennant TR, Lowe S, Le MM, Kogan SC. Myc Drives Chromosomal Gain in Acute Myeloid Leukemia Blood. 112: 792-792. DOI: 10.1182/Blood.V112.11.792.792  0.698
2008 Nakamura J, Phong C, Kogan S, Vandenberg S, Pieper R, Shannon K. Fractionated Cranial Irradiation Induces a Distinctive Pattern of Second Malignant Neoplasms in Nf1 Mutant Mice International Journal of Radiation Oncology*Biology*Physics. 72: S83. DOI: 10.1016/J.Ijrobp.2008.06.953  0.396
2007 Omidvar N, Kogan S, Beurlet S, le Pogam C, Janin A, West R, Noguera ME, Reboul M, Soulie A, Leboeuf C, Setterblad N, Felsher D, Lagasse E, Mohamedali A, Thomas NS, et al. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Research. 67: 11657-67. PMID 18089795 DOI: 10.1158/0008-5472.Can-07-0196  0.496
2007 Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood. 110: 719-26. PMID 17420284 DOI: 10.1182/Blood-2007-01-068809  0.476
2007 Kogan SC. Mouse models of acute promyelocytic leukemia. Current Topics in Microbiology and Immunology. 313: 3-29. PMID 17217036 DOI: 10.1007/978-3-540-34594-7_2  0.414
2007 Bergerson RJ, Collier LS, Allaei R, Silverstein KA, Lamblin AF, Wolff L, Kogan SC, Kersey JH, Adams DJ, Largaespada DA. Novel Mll-AF9 Cooperating Genes Identified in a Leukemogenesis Screen Using Retroviral Mutagenesis. Blood. 110: 825-825. DOI: 10.1182/Blood.V110.11.825.825  0.451
2007 Li Q, Haigis K, McDaniel A, Huang B, Miller M, Shieh A, Kogan S, Wolff L, Jacks T, Shannon K. Expressing N-RasG12D from the Endogenous Promoter Induces Myeloproliferative Disease (MPD) and Cooperates with Retroviral Insertional Mutagenesis (RIM) To Generate Acute Myeloid Leukemia (AML). Blood. 110: 1616-1616. DOI: 10.1182/Blood.V110.11.1616.1616  0.672
2006 Forsberg EC, Serwold T, Kogan S, Weissman IL, Passegué E. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell. 126: 415-26. PMID 16873070 DOI: 10.1016/J.Cell.2006.06.037  0.369
2006 Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP, Le Beau MM, Kogan SC, Castilla LH. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell. 9: 57-68. PMID 16413472 DOI: 10.1016/J.Ccr.2005.12.014  0.405
2006 Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene. 25: 1974-9. PMID 16331271 DOI: 10.1038/Sj.Onc.1209216  0.33
2006 Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC, Chen GQ. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood. 107: 698-707. PMID 16166593 DOI: 10.1182/blood-2005-03-1278  0.414
2006 Sevcikova S, Lee BD, Kogan SC. SU11657 Cooperates with Doxorubicin To Increase Survival of Leukemic Mice. Blood. 108: 4572-4572. DOI: 10.1182/BLOOD.V108.11.4572.4572  0.392
2006 Rosen GP, Kogan SC. Acute Promyelocytic Leukemia Stem Cell Derived from Leukemic Progenitor. Blood. 108: 235-235. DOI: 10.1182/BLOOD.V108.11.235.235  0.336
2005 Yamashita N, Osato M, Huang L, Yanagida M, Kogan SC, Iwasaki M, Nakamura T, Shigesada K, Asou N, Ito Y. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. British Journal of Haematology. 131: 495-507. PMID 16281942 DOI: 10.1111/j.1365-2141.2005.05793.x  0.448
2005 Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J, Borowsky A, Horvai A, Kogan SC, Bonifas J, Huey B, Jacks TE, Albertson DG, Shannon KM. Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell. 8: 337-48. PMID 16226708 DOI: 10.1016/J.Ccr.2005.08.011  0.305
2005 Lallemand-Breitenbach V, Zhu J, Kogan S, Chen Z, de Thé H. Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia. Nature Reviews. Cancer. 5: 821-7. PMID 16175176 DOI: 10.1038/Nrc1719  0.429
2005 Zhu J, Zhou J, Peres L, Riaucoux F, Honoré N, Kogan S, de Thé H. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell. 7: 143-53. PMID 15710327 DOI: 10.1016/J.Ccr.2005.01.005  0.414
2005 Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. The Embo Journal. 24: 368-81. PMID 15635450 DOI: 10.1038/Sj.Emboj.7600521  0.398
2005 Fischbach NA, Rozenfeld S, Shen W, Fong S, Chrobak D, Ginzinger D, Kogan SC, Radhakrishnan A, Le Beau MM, Largman C, Lawrence HJ. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood. 105: 1456-66. PMID 15522959 DOI: 10.1182/blood-2004-04-1583  0.444
2005 Padua R, Omidvar N, Kogan S, Phan T, West R, Felsher D, Weissmann I, Thomas S, Whittaker J, Janin A, Pla M, Muftis G, Bishop J, Chomienne C. O-14 A reversible two-step model ofMDS/preleukemia: Transgenic mice expressing inducible BCL2 and mutant NRAS Leukemia Research. 29: S5. DOI: 10.1016/S0145-2126(05)80013-X  0.435
2004 Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood. 103: 4243-50. PMID 14982883 DOI: 10.1182/Blood-2003-08-2650  0.351
2004 Kogan SC, Phan VT, Sternsdorf T, Maunakea ML, Sohal J, Silletto A, Galimi F, Evans RM. Homodimerization of Retinoic Acid Receptor alpha through its Fusion Partners Underlies Pathogenesis of Acute Promyelocytic Leukemia. Blood. 104: 546-546. DOI: 10.1182/Blood.V104.11.546.546  0.332
2004 Kuo Y, Heilman S, Chen A, Liu PP, Gernstein R, Kogan S, Castilla LH. Cbfb-MYH11 Induces Expansion of a Lin-Kit+Sca1- Abnormal Progenitor Compartment that Predisposes Acute Myeloid Leukemia in Mice. Blood. 104: 543-543. DOI: 10.1182/Blood.V104.11.543.543  0.559
2004 Kogan SC, Maunakea ML, Himmel KL, Yin B, Le Beau MM, Largaespada DA. Cooperative Pathways to Acute Myeloid Leukemia Include the Combining of Transcription Factor Alterations: PML-RARα Cooperates with SOX4. Blood. 104: 3385-3385. DOI: 10.1182/Blood.V104.11.3385.3385  0.424
2004 Osato M, Yamashita N, Yanagida M, Huang L, Kogan S, Iwasaki M, Nakamura T, Shigesada K, Asou N, Ito Y. Identification of Cooperating Genetic Alterations in RUNX Leukemia Using the Mouse Model for the Human Familial Leukemia, FPD/AML. Blood. 104: 3383-3383. DOI: 10.1182/Blood.V104.11.3383.3383  0.544
2004 Rassool FV, Gaymes TJ, Brady N, Lea N, Pla M, Phan TH, Kogan S, Chomienne C, Thomas NS, Mafti GJ, Padua RA. Increased DNA Damage and Error-Prone Repair in MPD/MDS Mice with Disease Progression: Key Indicators for Increased Genomic Instability. Blood. 104: 200-200. DOI: 10.1182/Blood.V104.11.200.200  0.454
2004 Entin IA, Kogan SC. Discovery of Genes Involved in Experimental Pre-Leukemia to Leukemia Transition in Mice Using Expression Arrays. Blood. 104: 1109-1109. DOI: 10.1182/BLOOD.V104.11.1109.1109  0.449
2003 Padua RA, Larghero J, Robin M, le Pogam C, Schlageter MH, Muszlak S, Fric J, West R, Rousselot P, Phan TH, Mudde L, Teisserenc H, Carpentier AF, Kogan S, Degos L, et al. PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nature Medicine. 9: 1413-7. PMID 14566333 DOI: 10.1038/Nm949  0.342
2003 Hansen LA, Brown D, Virador V, Tanaka T, Andreola F, Strain K, Dancheck B, Riley R, Arbeit JM, De Luca LM, Kogan S, Yuspa SH. A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis. Cancer Research. 63: 5257-65. PMID 14500356  0.33
2003 Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia. Blood. 102: 1072-4. PMID 12689927 DOI: 10.1182/Blood-2003-01-0155  0.493
2003 Sohal J, Phan VT, Chan PV, Davis EM, Patel B, Kelly LM, Abrams TJ, O'Farrell AM, Gilliland DG, Le Beau MM, Kogan SC. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood. 101: 3188-97. PMID 12515727 DOI: 10.1182/Blood-2002-06-1800  0.403
2003 Truong BT, Lee YJ, Lodie TA, Park DJ, Perrotti D, Watanabe N, Koeffler HP, Nakajima H, Tenen DG, Kogan SC. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood. 101: 1141-8. PMID 12393450 DOI: 10.1182/blood-2002-05-1374  0.311
2002 Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V, Zhu J, Janin A, Daniel MT, Gourmel B, Degos L, Dombret H, Lanotte M, De Thé H. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. The Journal of Experimental Medicine. 196: 1373-80. PMID 12438428 DOI: 10.1084/Jem.20021129  0.37
2002 Le Beau MM, Bitts S, Davis EM, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood. 99: 2985-91. PMID 11929790 DOI: 10.1182/blood.V99.8.2985  0.44
2001 Blaydes SM, Kogan SC, Truong BT, Gilbert DJ, Jenkins NA, Copeland NG, Largaespada DA, Brannan CI. Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia. Journal of Virology. 75: 9427-34. PMID 11533205 DOI: 10.1128/Jvi.75.19.9427-9434.2001  0.387
2001 Kogan SC. Acute promyelocytic leukemia: a view from a mouse. Blood Cells, Molecules & Diseases. 26: 620-5. PMID 11358354 DOI: 10.1006/BCMD.2000.0345  0.404
2001 Kogan SC, Brown DE, Shultz DB, Truong BT, Lallemand-Breitenbach V, Guillemin MC, Lagasse E, Weissman IL, Bishop JM. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. The Journal of Experimental Medicine. 193: 531-43. PMID 11181704 DOI: 10.1084/Jem.193.4.531  0.517
2000 Kogan SC, Hong SH, Shultz DB, Privalsky ML, Bishop JM. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood. 95: 1541-50. PMID 10688806  0.512
1998 Kogan SC, Lagasse E, Atwater S, Bae SC, Weissman I, Ito Y, Bishop JM. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proceedings of the National Academy of Sciences of the United States of America. 95: 11863-8. PMID 9751756  0.475
1997 Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 94: 2551-6. PMID 9122233 DOI: 10.1073/Pnas.94.6.2551  0.492
1990 Kogan S, Gitschier J. Mutations and a polymorphism in the factor VIII gene discovered by denaturing gradient gel electrophoresis Proceedings of the National Academy of Sciences of the United States of America. 87: 2092-2096. PMID 2107542 DOI: 10.1073/Pnas.87.6.2092  0.304
Show low-probability matches.